AAAAAA
Results:
1-20
|
Results: 20
Authors:
Jacobson, P
Ng, J
Ratanatharathorn, V
Uberti, J
Brundage, RC
Citation: P. Jacobson et al., Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients, BONE MAR TR, 28(8), 2001, pp. 753-758
Authors:
Ratanatharathorn, V
Ayash, L
Lazarus, HM
Fu, J
Uberti, JP
Citation: V. Ratanatharathorn et al., Chronic graft-versus-host disease: clinical manifestation and therapy, BONE MAR TR, 28(2), 2001, pp. 121-129
Authors:
Ayash, LJ
Clarke, M
Silver, SM
Braun, T
Uberti, J
Ratanatharathorn, V
Reynolds, C
Ferrara, J
Broun, ER
Adams, PT
Citation: Lj. Ayash et al., Double dose-intensive chemotherapy with autologous stem cell support for relapsed and refractory testicular cancer: the University of Michigan experience and literature review, BONE MAR TR, 27(9), 2001, pp. 939-947
Authors:
Reynolds, C
Ratanatharathorn, V
Adams, P
Braun, T
Silver, S
Ayash, L
Carson, E
Eisbruch, A
Dawson, LA
McDonagh, K
Ferrara, J
Uberti, J
Citation: C. Reynolds et al., Allogeneic stem cell transplantation reduces disease progression compared to autologous transplantation in patients with multiple myeloma, BONE MAR TR, 27(8), 2001, pp. 801-807
Authors:
Ratanatharathorn, V
Lorvidhaya, V
Maoleekoonpairoj, S
Phromratanapongse, P
Sirilerttrakul, S
Kraipiboon, P
Cheirsilpa, A
Tangkaratt, S
Srimuninnimit, V
Pattaranutaporn, P
Citation: V. Ratanatharathorn et al., Phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer, LUNG CANC, 31(2-3), 2001, pp. 257-265
Authors:
Hanna, E
Shrieve, DC
Ratanatharathorn, V
Xia, XQ
Breau, R
Suen, J
Lil, SL
Citation: E. Hanna et al., A novel alternative approach for prediction of radiation response of squamous cell carcinoma of head and neck, CANCER RES, 61(6), 2001, pp. 2376-2380
Authors:
Kollman, C
Howe, CWS
Anasetti, C
Antin, JH
Davies, SM
Filipovich, AH
Hegland, J
Kamani, N
Kernan, NA
King, R
Ratanatharathorn, V
Weisdorf, D
Confer, DL
Citation: C. Kollman et al., Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age, BLOOD, 98(7), 2001, pp. 2043-2051
Authors:
Ratanatharathorn, V
Ferrara, JLM
Citation: V. Ratanatharathorn et Jlm. Ferrara, Hemopoietic stem cell transplantation, THERAPEUTIC IMMUNOLOGY, SECOND EDITION, 2001, pp. 496-517
Authors:
Ratanatharathorn, V
Powers, WE
Moss, WT
Perez, C
Citation: V. Ratanatharathorn et al., Bone metastases: Ongoing controversies in fractionation schedules - Response to letter to the editor from Dr. Jackson Wu and Dr. Andrea Bezjak, INT J RAD O, 48(3), 2000, pp. 908-909
Authors:
Ratanatharathorn, V
Powers, WE
Moss, WT
Perez, CA
Citation: V. Ratanatharathorn et al., Fractionated radiotherapy for metastatic bone pain: Evidence-based medicine or ... ? - Response, INT J RAD O, 46(3), 2000, pp. 682-683
Authors:
Ratanatharathorn, V
Powers, WE
Moss, WT
Perez, C
Citation: V. Ratanatharathorn et al., Bone metastasis: Review and critical analysis of random allocation trial of local field treatment: Regarding Ratanatharathorn ET AL-IJROB 44(1): 1-18; 1999 - Response, INT J RAD O, 46(2), 2000, pp. 518-518
Authors:
Yanik, G
Levine, JE
Ratanatharathorn, V
Dunn, R
Ferrara, J
Hutchinson, RJ
Citation: G. Yanik et al., Tacrolimus (FK506) and methotrexate as prophylaxis for acute graft-versus-host disease in pediatric allogeneic stem cell transplantation, BONE MAR TR, 26(2), 2000, pp. 161-167
Authors:
Cronin, S
Uberti, JP
Ayash, LJ
Raith, C
Ratanatharathorn, V
Citation: S. Cronin et al., Use of amifostine as a chemoprotectant during high-dose chemotherapy in autologous peripheral blood stem cell transplantation, BONE MAR TR, 26(11), 2000, pp. 1247-1249
Authors:
Sirisriro, R
Boonkitticharoen, V
Kraiphibul, P
Ratanatharathorn, V
Sumboonnanon, K
Kanjanapitak, A
Kuhapremma, T
Sritara, C
Puchinda, D
Chouplywech, P
Jalayondeja, V
Pekanan, P
Rochanawutanon, M
Intaramarn, C
Ayudhya, ANN
Chokesuwathana, P
Citation: R. Sirisriro et al., Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with Tc-99m scintigraphy, HEP-GASTRO, 47(32), 2000, pp. 405-413
Authors:
Ungkanont, A
Jootar, S
Ratanatharathorn, V
Chiernsilp, A
Citation: A. Ungkanont et al., High dose chemotherapy and peripheral blood stem cell transplantation for high risk primary breast cancer: A single center experience in Thailand, A P J ALLER, 18(4), 2000, pp. 215-220
Authors:
Nash, RA
Antin, JH
Karanes, C
Fay, JW
Avalos, BR
Yeager, AM
Przepiorka, D
Davies, S
Petersen, FB
Bartels, P
Buell, D
Fitzsimmons, W
Anasetti, C
Storb, R
Ratanatharathorn, V
Citation: Ra. Nash et al., Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors, BLOOD, 96(6), 2000, pp. 2062-2068
Authors:
Ratanatharathorn, V
Carson, E
Reynolds, C
Ayash, LJ
Levine, J
Yanik, G
Silver, SM
Ferrara, JLM
Uberti, JP
Citation: V. Ratanatharathorn et al., Anti-CD20 chimeric monoclonal antibody treatment of refractory immune-mediated thrombocytopenia in a patient with chronic graft-versus-host disease, ANN INT MED, 133(4), 2000, pp. 275-279
Authors:
Uberti, JP
Cronin, S
Ratanatharathorn, V
Citation: Jp. Uberti et al., Optimum use of tacrolimus in the prophylaxis of graft versus host disease, BIODRUGS, 11(5), 1999, pp. 343-358
Authors:
Ratanatharathorn, V
Powers, WE
Moss, WT
Perez, CA
Citation: V. Ratanatharathorn et al., Bone metastasis: Review and critical analysis of random allocation trials of local field treatment, INT J RAD O, 44(1), 1999, pp. 1-18
Authors:
Laohavinij, S
Maoleekoonpairoj, S
Cheirsilpa, A
Maneechavakajorn, J
Sirachainant, E
Arpornvivat, W
Jaisathaporn, K
Ratanatharathorn, V
Citation: S. Laohavinij et al., Phase II study of paclitaxel and carboplatin for advanced non-small-cell lung cancer, LUNG CANC, 26(3), 1999, pp. 175-185
Risultati:
1-20
|